ePlex Blood Culture Identification Gram Negative (BCID-GN) Panel

FDA 510(k) K213236 · Genmark Diagnostics, Incorporated

Substantially Equivalent

510(k) numberK213236

Submission

Device name
ePlex Blood Culture Identification Gram Negative (BCID-GN) Panel
Applicant
Genmark Diagnostics, Incorporated
Carlsbad, CA, US
Received
September 30, 2021
Decision date
April 27, 2022
Decision
Substantially Equivalent (SESE)
Type
Traditional 510(k)
Summary
510(k) summary available from FDA

Official FDA 510(k) record

Device classification

Product code
PEN – Gram-Negative Bacteria And Associated Resistance Markers
Device class
Class II (moderate risk)
Regulation
21 CFR 866.3365
Specialty
Microbiology

A qualitative multiplexed in vitro diagnostic device to detect and identify gram-negative bacteria and resistance markers in positive blood cultures.

Other 510(k)s with product code PEN

510(k)DeviceApplicantDecision
K243013LIAISON PLEX Gram-Negative Blood Culture AssayPEN · Traditional Luminex Corporation04/18/2025SE
K243759BIOFIRE Blood Culture Identification 2 (BCID2) Panel (RFIT-ASY-0147 (30 pack)…PEN · Special Biofire Diagnostics, LLC12/20/2024SE
K193519BioFire Blood Culture Identification 2 (BCID2) PanelPEN · Traditional Biofire Diagnostics, LLC03/18/2020SE
K190341iC-GN iC-Cassette for use on the iC-SystemPEN · Traditional Icubate, Inc.06/28/2019SE
K182619ePlex Blood Culture Identification Gram Negative (BCID-GN) PanelPEN · Traditional Genmark Diagnostics, Incorporated04/12/2019SE
K181493FilmArray Blood Culture Identification (BCID) PanelPEN · Special Biofire Diagnostics, LLC07/05/2018SE
K160457FilmArray Blood Culture Identification (BCID) panel for use with FilmArray TorchPEN · Special Biofire Diagnostics, LLC03/15/2016SE
K143171FilmArray Blood Culture Identification (BCID) Panel for use with the FilmArray 2.0PEN · Traditional Biofire Diagnostics, LLC01/30/2015SE
K132843Verigene Gram Negative Blood Culture Nucleic Acid Test (Bc-Gn)PEN · Traditional Nanosphere, Inc.01/08/2014SE
K130914Filmarray Blood Culture Identification (Bcid) PanelPEN · Traditional Biofire Diagnostics, Inc.06/21/2013SE

More from Biofire Diagnostics, Inc.

510(k)DeviceDecision
K182619ePlex Blood Culture Identification Gram Negative (BCID-GN) PanelPEN · Traditional 04/12/2019SE
K182690ePlex Blood Culture Identification Panel Fungal Pathogen (BCID-FP) PanelPEO · Traditional 12/21/2018SE
K181663ePlex Blood Culture Identification Panel - Gram Positive (BCID-GP) PanelPAM · Traditional 12/20/2018SE
K163652ePlex InstrumentNSU · Traditional 06/09/2017SE
K163636ePlex Respiratory Pathogen PanelOCC · Traditional 06/09/2017SE
K152612eSensor Warfarin Sensitivity Saliva TestODW · Traditional 05/26/2016SE
K110786Esensor Warfarin Sensitivity Saliva TestNSU · Traditional 12/02/2011SE

Questions and answers

When was ePlex Blood Culture Identification Gram Negative (BCID-GN) Panel cleared by the FDA?

ePlex Blood Culture Identification Gram Negative (BCID-GN) Panel (K213236) received a 510(k) decision of Substantially Equivalent on April 27, 2022, 209 days after the submission was received.

What is the product code of K213236?

The FDA product code is PEN – Gram-Negative Bacteria And Associated Resistance Markers, a Class II (moderate risk) device regulated under 21 CFR 866.3365.